Frankfurt - Delayed Quote EUR
GenSight Biologics S.A. (G49N.F)
0.2325
+0.0080
+(3.56%)
At close: April 28 at 8:18:31 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,500
1,500
1,267
2,582
5,276
Operating Expense
17,313
17,313
30,963
30,417
33,401
Operating Income
-15,813
-15,813
-29,696
-27,835
-28,125
Net Non Operating Interest Income Expense
-2,486
-2,486
-3,153
-2,972
-2,166
Pretax Income
-13,981
-13,981
-26,221
-27,619
-28,615
Tax Provision
21
21
--
5
2
Net Income Common Stockholders
-14,001
-14,001
-26,220
-27,625
-28,617
Diluted NI Available to Com Stockholders
-14,001
-14,001
-26,220
-27,625
-28,617
Basic EPS
-0.15
--
-0.54
-0.60
-0.63
Diluted EPS
-0.15
--
-0.54
-0.60
-0.63
Basic Average Shares
95,755.4630
--
48,316.3390
46,330.3030
45,150.5920
Diluted Average Shares
95,755.4630
--
48,316.3390
46,330.3030
45,150.5920
Total Operating Income as Reported
-15,813
-15,813
-29,696
-27,835
-28,126
Rent Expense Supplemental
2
--
--
--
--
Total Expenses
17,313
17,313
30,963
30,417
33,401
Net Income from Continuing & Discontinued Operation
-14,001
-14,001
-26,220
-27,625
-28,617
Normalized Income
-18,133
-18,133
-33,061
-30,161
-29,926
Interest Income
1
1
--
--
--
Interest Expense
1,553
1,553
3,152
2,650
2,166
Net Interest Income
-2,486
-2,486
-3,153
-2,972
-2,166
EBIT
-12,428
-12,428
-23,069
-24,969
-26,449
EBITDA
-11,369
-11,369
-20,890
-23,908
-25,521
Reconciled Depreciation
1,059
1,059
2,179
1,061
928
Net Income from Continuing Operation Net Minority Interest
-14,001
-14,001
-26,220
-27,625
-28,617
Total Unusual Items Excluding Goodwill
4,132
4,132
6,841
2,536
1,309
Total Unusual Items
4,132
4,132
6,841
2,536
1,309
Normalized EBITDA
-15,501
-15,501
-27,731
-26,444
-26,830
12/31/2021 - 7/14/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade